NCT02289261View on ClinicalTrials.gov

A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Chronic Pain
Interventions
DRUG

Morphine

Morphine, 0.02 mg/kg PCA bolus dose with 10 minutes lock-out interval

DRUG

Morphine plus dexmedetomidine

Morphine 0.02 mg/kg plus dexmedetomidine 0.1 microgram/kg PCA bolus dose with 10 minutes lock-out interval

Trial Locations (1)

01130

Cukurova University Faculty of Medicine Research Hospital, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT02289261 - A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain | Biotech Hunter | Biotech Hunter